未破裂型异位妊娠临床治疗后的输卵管通畅情况。
Tubal patency after clinical treatment of unruptured ectopic pregnancy.
作者信息
Elito J, Han K K, Camano L
机构信息
Department of Obstetrics of the Escola Paulista de Medicina, Federal University of São Paulo, Rua Maria Carolina, 68, Jardim Paulistano CEP-01445-000, São Paulo, Brazil.
出版信息
Int J Gynaecol Obstet. 2005 Mar;88(3):309-13. doi: 10.1016/j.ijgo.2004.12.018. Epub 2005 Jan 22.
OBJECTIVE
To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy.
METHOD
Of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly.
RESULTS
Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups.
CONCLUSION
Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management.
目的
评估输卵管妊娠临床治疗后通过子宫输卵管造影术检测输卵管通畅情况。
方法
1994年4月至2002年2月期间，80例输卵管妊娠临床治疗后接受子宫输卵管造影术的患者，其中30例接受单次50mg/m²剂量甲氨蝶呤肌肉注射治疗（n = 30），50例进行期待治疗。
结果
甲氨蝶呤治疗后同侧输卵管通畅率为84%，期待治疗后为78%。此外，甲氨蝶呤治疗后对侧输卵管通畅率为97%，期待治疗后为92%。两组之间无统计学显著差异。
结论
本研究结果表明，甲氨蝶呤治疗和期待治疗后的输卵管通畅率相似。
Zotero 插件